Publication | Closed Access

Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy

Cyp3a4 Genetic PolymorphismsPlasma Carbamazepine ConcentrationsMedicineGenetic EpidemiologyHuman PolymorphismPharmacogenomicsPharmacologyNeurogeneticsChinese Patients